EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Prediction of Pancreatic Cancer Risk in Patients with New-Onset Diabetes

Salman Khan

Visceral Medicine · 09.01.2025 · 41 (5) · 254-261

DOI: 10.1159/000543479 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Visceral Medicine, online erschienen am 09.01.2025. Verfasst von Salman Khan. Beteiligte Einrichtung: Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Pancreatic cancer remains the fourth leading cause of cancer-related deaths in the USA despite its lower incidence, primarily due to late-stage diagnosis. While early detection could double survival rates, screening the general population is not cost-effective due to low disease prevalence and technical limitations. Summary: This review examines the relationship between diabetes and pancreatic cancer, highlighting how diabetes types differently impact cancer risk. New-onset diabetes triples pancreatic cancer risk compared to the general population, while long-standing diabetes doubles it. Several prediction models have been developed to identify high-risk individuals among new-onset diabetes patients, with recent models achieving AUCs up to 0.91. Current biomarkers like CA 19-9 show improved utility when combined with other clinical parameters, though they remain inadequate for general population screening. Cost-effectiveness analysis suggests that screening becomes viable when 3-year cancer incidence exceeds 2% and 25% of cases are detected at a localized stage. Key Messages: (1) New-onset diabetes presents a stronger risk factor for pancreatic cancer than long-standing diabetes. (2) Multiple prediction models show promise but face challenges with missing data and cross-population validation. (3) Integrated approaches combining clinical parameters, biomarkers, and machine learning offer the most promising path forward for early detection. (4) Current detection rates fall below cost-effectiveness thresholds, highlighting the need for improved screening strategies.

Schlagwörter

Stichwörter der Autor:innen

CancerDiabetesMalignancyPancreasScreening

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Department of Internal Medicine, West Virginia University School of Medicine, Morgantown, WV, USA.

Zitieren

APA

Khan, S. (2025). Prediction of Pancreatic Cancer Risk in Patients with New-Onset Diabetes. Visceral Medicine, 41(5), 254-261. https://doi.org/10.1159/000543479

Vancouver

Khan S. Prediction of Pancreatic Cancer Risk in Patients with New-Onset Diabetes. Visceral Medicine. 2025;41(5):254-261. doi:10.1159/000543479

BibTeX
@article{Khan2025,
  author = {Khan, Salman},
  title = {Prediction of Pancreatic Cancer Risk in Patients with New-Onset Diabetes},
  journal = {Visceral Medicine},
  year = {2025},
  volume = {41},
  number = {5},
  pages = {254--261},
  doi = {10.1159/000543479}
}
Kostenlos starten →